Clinical trials
Phase 1 Dyslipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
139 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 12 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 8 |
| 2023 | 10 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 111 |
| Unknown status | 8 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Not yet recruiting | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 38 |
| AstraZeneca | 16 |
| Merck Sharp & Dohme LLC | 9 |
| Pfizer | 8 |
| Eli Lilly and Company | 5 |
| AJU Pharm Co., Ltd. | 3 |
| Korea United Pharm. Inc. | 3 |
| Xention Ltd | 3 |
| IlDong Pharmaceutical Co Ltd | 2 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 139 |
| Hypertension | 30 |
| Hypercholesterolemia | 17 |
| Diabetes Mellitus, Type 2 | 9 |
| Hyperlipidemias | 8 |
| Metabolic Diseases | 6 |
| Diabetes Mellitus | 5 |
| Hypertriglyceridemia | 5 |
| Lipid Metabolism Disorders | 5 |
| Non-alcoholic Fatty Liver Disease | 5 |
Trials
Showing 76 to 100 of 139. Each trial links to its page on Pharma Observatory.
39 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.